|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.58 USD | +1.06% |
|
-4.27% | +2.06% |
| 03-06 | Tylenol use among women dropped after Trump tied it to autism, Lancet analysis shows | RE |
| 03-05 | Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating | MT |
| Capitalization | 33.33B 28.92B 26.14B 24.96B 45.41B 3,077B 46.99B 311B 124B 1,470B 125B 122B 5,307B | P/E ratio 2026 * |
18.5x | P/E ratio 2027 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise value | 40.93B 35.51B 32.1B 30.65B 55.75B 3,779B 57.71B 382B 152B 1,806B 154B 150B 6,517B | EV / Sales 2026 * |
2.63x | EV / Sales 2027 * | 2.54x |
| Free-Float |
99.66% | Yield 2026 * |
4.9% | Yield 2027 * | 5.02% |
Last Transcript: Kenvue Inc.
| 1 day | +1.06% | ||
| 1 week | -4.27% | ||
| Current month | -7.92% | ||
| 1 month | -5.86% | ||
| 3 months | +2.30% | ||
| 6 months | -3.53% | ||
| Current year | +2.06% |
| 1 week | 17.36 |  | 18.24 |
| 1 month | 17.36 | | 19.18 |
| Current year | 16.56 | | 19.18 |
| 1 year | 14.02 | | 25.17 |
| 3 years | 14.02 | | 27.8 |
| 5 years | 14.02 | | 27.8 |
| 10 years | 14.02 | | 27.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kirk Perry
CEO | Chief Executive Officer | 59 | 13/07/2025 |
Amit Banati
DFI | Director of Finance/CFO | 57 | 11/05/2025 |
| Chief Tech/Sci/R&D Officer | 57 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Larry Merlo
CHM | Chairman | 70 | 30/04/2023 |
Vasant M. Prabhu
BRD | Director/Board Member | 66 | 03/05/2023 |
Richard Allison
BRD | Director/Board Member | 58 | 07/05/2023 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -1.79% | 0.09% | 321 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.06% | -4.27% | -24.05% | - | 33.33B | |
| +0.39% | -1.30% | -10.05% | +9.77% | 350B | |
| -0.15% | -2.09% | -5.08% | +5.90% | 141B | |
| +1.31% | -4.86% | -1.67% | +24.49% | 70.5B | |
| +1.08% | -2.95% | -0.68% | -12.02% | 59.82B | |
| +2.80% | -6.33% | +33.90% | -63.04% | 30.49B | |
| -0.52% | -6.66% | -41.31% | -29.28% | 19.85B | |
| +0.69% | -0.26% | -11.86% | -5.45% | 19.08B | |
| -2.32% | -7.94% | +0.20% | +12.30% | 11.66B | |
| -1.27% | -5.24% | -9.47% | -13.38% | 8.82B | |
| Average | +0.33% | -5.34% | -7.01% | -7.86% | 74.38B | |
| Weighted average by Cap. | +0.52% | -3.89% | -7.10% | +3.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.54B 13.48B 12.19B 11.64B 21.17B 1,435B 21.91B 145B 57.61B 686B 58.33B 57.08B 2,475B | 15.95B 13.84B 12.51B 11.94B 21.73B 1,472B 22.49B 149B 59.11B 704B 59.85B 58.57B 2,539B |
| Net income | 1.82B 1.58B 1.43B 1.36B 2.48B 168B 2.56B 16.97B 6.74B 80.22B 6.82B 6.68B 290B | 2B 1.73B 1.57B 1.5B 2.72B 184B 2.81B 18.64B 7.4B 88.08B 7.49B 7.33B 318B |
| Net Debt | 7.6B 6.59B 5.96B 5.69B 10.35B 701B 10.71B 70.92B 28.16B 335B 28.51B 27.9B 1,210B | 7.14B 6.19B 5.6B 5.34B 9.72B 659B 10.06B 66.61B 26.45B 315B 26.78B 26.21B 1,136B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/03/26 | 17.60 $ | +1.24% | 2,375,090 |
| 12/03/26 | 17.39 $ | -1.47% | 26,381,010 |
| 11/03/26 | 17.65 $ | -1.73% | 19,059,671 |
| 10/03/26 | 17.96 $ | -1.10% | 30,105,464 |
| 09/03/26 | 18.16 $ | -1.25% | 29,336,888 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- KVUE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition